9jkv: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "9jkv" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
 
Line 1: Line 1:
'''Unreleased structure'''


The entry 9jkv is ON HOLD
==IBC-HCAR3-Gi complex==
 
<StructureSection load='9jkv' size='340' side='right'caption='[[9jkv]], [[Resolution|resolution]] 3.26&Aring;' scene=''>
Authors: Binghao, Z., Fang, Y.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[9jkv]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9JKV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9JKV FirstGlance]. <br>
Description: IBC-HCAR3-Gi complex
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.26&#8491;</td></tr>
[[Category: Unreleased Structures]]
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1EB5:1-propan-2-ylbenzotriazole-5-carboxylic+acid'>A1EB5</scene></td></tr>
[[Category: Binghao, Z]]
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9jkv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9jkv OCA], [https://pdbe.org/9jkv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9jkv RCSB], [https://www.ebi.ac.uk/pdbsum/9jkv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9jkv ProSAT]</span></td></tr>
[[Category: Fang, Y]]
</table>
== Function ==
[https://www.uniprot.org/uniprot/HCAR3_HUMAN HCAR3_HUMAN] Receptor for 3-OH-octanoid acid mediates a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates. Acts as a low affinity receptor for nicotinic acid. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet.<ref>PMID:12522134</ref> <ref>PMID:19561068</ref>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Binghao Z]]
[[Category: Fang Y]]